Diatreme Resources (ASX:DRX) is an emerging Australian producer of mineral and silica sands based in Brisbane. Our key projects comprise the Northern Silica Project and Galalar Silica Sand Project in Far North Queensland, located next to the world's biggest silica sand mine at Cape Flattery.
Copyright 2024 – Finance News Network
Source: Finance News Network
15 Jan 2021 - Famed investor, author and market analyst Jim Rogers discusses the impact of the COVID-19 vaccine rollout, Chinese wine stocks, the bond bubble, why he is bullish on commodities, allegations of currency manipulation and how Aussie investors can get ahead.
Read More16 Aug 2023 - Dr John Melki - CEO and Director - Genetic Signatures (ASX:GSS) is transforming molecular diagnostics via streamlined sample processing methods linked to highly multiplexed real-time PCR screening assays.
Read More31 Mar 2021 - Recce Pharmaceuticals Limited (ASX:RCE, FSE:R9Q) CEO and Managing Director James Graham talks about progress with the company's lead anti-infective candidate Recce 327, its expanding portfolio of synthetic anti-infectives targeting viral pathogens and a broad range of bacteria, clinical trial results and priorities for 2021.
Read More16 Oct 2023 - In this interview, the Managing Director of Cooper Metals (ASX:CPM) discusses their active drilling program at the Mount Isa region, focusing on copper and gold prospects.
Read More08 Sep 2021 - Knosys Limited (ASX:KNO) Managing Director John Thompson discusses FY21 results and the outlook for FY22.
Read More12 Aug 2020 - Centuria Capital Group (ASX:CNI) Joint CEO John McBain discusses full year 2020 results, acquisition of Augusta Capital, and guidance for FY21.
Read More30 Sep 2022 - WT Financial Group Limited (ASX:WTL) Founder and Managing Director Keith Cullen discusses financial highlights, 2023 guidance, the value of scale, the vision for financial advice and main shareholders.
Read More07 Aug 2020 - Australian Banking Association CEO, Anna Bligh discusses how the banking sector is responding to COVID-19 and what customers can expect from the new banking code.
Read More31 Oct 2022 - Shaw and Partners Chief Investment Officer Martin Crabb discusses the market outlook, giving general advice on investment implications.
Read More24 Jun 2020 - Immutep (ASX:IMM) CEO, Marc Voigt provides an update on its clinical trials including metastatic breast cancer (MBC), its global leadership under Chief Scientist and Medical Officer, Professor Frederic Triebel, and the growing interest by big pharma in immuno-therapies.
Read More
